Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

A phase II study of cisplatin /S-1 in patients with carcinomas of unknown primary site.

Tsuya A, Kurata T, Tamiya A, Okamoto I, Ueda S, Sakai D, Sugimoto N, Matsumoto K, Goto I, Yamamoto N, Fukuoka M, Nakagawa K.

Invest New Drugs. 2013 Dec;31(6):1568-72. doi: 10.1007/s10637-013-0014-0. Epub 2013 Aug 24.

PMID:
23975509
2.

Combination chemotherapy of S-1 and low-dose cisplatin for advanced gastric cancer.

Tsujitani S, Fukuda K, Kaibara N.

Gastric Cancer. 2003;6 Suppl 1:50-7.

PMID:
12775021
3.

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, Toh Y, Nagaie T, Takagi S, Yamamura Y, Yanaoka K, Orita H, Takeuchi M.

Lancet Oncol. 2008 Mar;9(3):215-21. doi: 10.1016/S1470-2045(08)70035-4. Epub 2008 Feb 20.

PMID:
18282805
4.
5.

Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.

Lee SJ, Cho SH, Yoon JY, Hwang JE, Bae WK, Shim HJ, Chung IJ.

Cancer Chemother Pharmacol. 2009 Dec;65(1):159-66. doi: 10.1007/s00280-009-1019-4. Epub 2009 May 29.

PMID:
19479256
6.

Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study.

Lenz HJ, Lee FC, Haller DG, Singh D, Benson AB 3rd, Strumberg D, Yanagihara R, Yao JC, Phan AT, Ajani JA.

Cancer. 2007 Jan 1;109(1):33-40.

7.

A phase II trial of oral UFT plus cisplatin (CDDP) in patients with non-small cell lung cancer (NSCLC).

Saito J, Nakai Y, Saijo Y, Nukiwa T, Koinumaru S, Matsuura Y, Aso N, Yamane Y, Tsukamoto T, Sayama T, Nakabayashi T.

Lung Cancer. 2001 Feb-Mar;31(2-3):285-93.

PMID:
11165409
8.

Phase I/II study of s-1 plus cisplatin combination chemotherapy in patients with advanced/recurrent head and neck cancer.

Fujii M, Tomita K, Nishijima W, Tsukuda M, Hasegawa Y, Ishitoya J, Yamane H, Homma A, Tomita T.

Jpn J Clin Oncol. 2010 Mar;40(3):214-21. doi: 10.1093/jjco/hyp153. Epub 2009 Nov 23.

9.

Transarterial infusion chemotherapy with cisplatin plus S-1 for hepatocellular carcinoma treatment: a phase I trial.

Terazawa T, Kondo S, Hosoi H, Morizane C, Shimizu S, Mitsunaga S, Ikeda M, Ueno H, Okusaka T.

BMC Cancer. 2014 Apr 30;14:301. doi: 10.1186/1471-2407-14-301.

10.

Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma.

Ajani JA, Lee FC, Singh DA, Haller DG, Lenz HJ, Benson AB 3rd, Yanagihara R, Phan AT, Yao JC, Strumberg D.

J Clin Oncol. 2006 Feb 1;24(4):663-7.

11.

Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases.

Fushida S, Fujimura T, Oyama K, Yagi Y, Kinoshita J, Ohta T.

Anticancer Drugs. 2009 Sep;20(8):752-6. doi: 10.1097/CAD.0b013e32832ec02b.

PMID:
19543076
12.

A phase I study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 in patients with advanced gastric cancer.

Kimura Y, Yano H, Imamura H, Fujitani K, Imano M, Tokunaga Y, Matsuoka M, Kurokawa Y, Shimokawa T, Takiuchi H, Tsujinaka T, Furukawa H.

Jpn J Clin Oncol. 2013 Feb;43(2):125-31. doi: 10.1093/jjco/hys204. Epub 2012 Dec 5.

13.

Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002).

Narahara H, Iishi H, Imamura H, Tsuburaya A, Chin K, Imamoto H, Esaki T, Furukawa H, Hamada C, Sakata Y.

Gastric Cancer. 2011 Mar;14(1):72-80. doi: 10.1007/s10120-011-0009-5. Epub 2011 Feb 23.

14.

[S-1 for gastric cancer-S-1 monotherapy and its progress].

Shitara K, Sakata Y, Kudou T, Munakata M.

Gan To Kagaku Ryoho. 2006 Jun;33 Suppl 1:43-51. Review. Japanese.

PMID:
16897971
15.

S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial.

Ichinose Y, Yoshimori K, Sakai H, Nakai Y, Sugiura T, Kawahara M, Niitani H.

Clin Cancer Res. 2004 Dec 1;10(23):7860-4.

16.

S-1 and Cisplatin With or Without Nimotuzumab for Patients With Untreated Unresectable or Metastatic Gastric Cancer: A Randomized, Open-Label Phase 2 Trial.

Du F, Zheng Z, Shi S, Jiang Z, Qu T, Yuan X, Sun Y, Song Y, Yang L, Zhao J, Wang J, Chi Y.

Medicine (Baltimore). 2015 Jun;94(23):e958. doi: 10.1097/MD.0000000000000958.

17.

Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study.

Ajani JA, Buyse M, Lichinitser M, Gorbunova V, Bodoky G, Douillard JY, Cascinu S, Heinemann V, Zaucha R, Carrato A, Ferry D, Moiseyenko V.

Eur J Cancer. 2013 Nov;49(17):3616-24. doi: 10.1016/j.ejca.2013.07.003. Epub 2013 Jul 27.

PMID:
23899532
18.

A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer.

Kim YJ, Im SA, Kim HG, Oh SY, Lee KW, Choi IS, Oh DY, Lee SH, Kim JH, Kim DW, Kim TY, Kim SW, Heo DS, Yoon YB, Bang YJ.

Ann Oncol. 2008 Jan;19(1):99-103. Epub 2007 Sep 9.

19.

S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer: a multi-institutional phase II trial (West Japan Thoracic Oncology Group 3706).

Ichinose Y, Seto T, Sasaki T, Yamanaka T, Okamoto I, Takeda K, Tanaka M, Katakami N, Sawa T, Kudoh S, Saka H, Nishimura Y, Nakagawa K, Fukuoka M.

J Thorac Oncol. 2011 Dec;6(12):2069-75. doi: 10.1097/JTO.0b013e3182307e5a.

PMID:
22052226
20.

Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.

Ohyanagi F, Yamamoto N, Horiike A, Harada H, Kozuka T, Murakami H, Gomi K, Takahashi T, Morota M, Nishimura T, Endo M, Nakamura Y, Tsuya A, Horai T, Nishio M.

Br J Cancer. 2009 Jul 21;101(2):225-31. doi: 10.1038/sj.bjc.6605152.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk